Assessment of 2012 Bioequivalence Standards for Warfarin
Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the 2012 bioequivalence statistical criteria for
warfarin, a narrow therapeutic index drug, set forth in the draft guidance issued by the Food
and Drug Administration (FDA).